Yatharth Hospital Approves ₹3,150 Crore Preferential Issue to Rasmalai Ltd.
Yatharth Hospital will raise ₹3,150 crore via preferential issue of shares and warrants to Rasmalai Limited. The Board approved increasing authorized share capital to ₹150 crore and amending Articles of Association. An EGM is scheduled for October 15, 2026, to approve these proposals, which include special rights for the investor.
The substantial amount of capital being raised through a preferential issue, along with changes in shareholding and board representation, will have a material impact on the company's financial structure and governance.
The company is undertaking a significant preferential issue, which will infuse capital and potentially lead to strategic partnerships or enhanced financial standing.
Yatharth Hospital & Trauma Care Services Limited announced a significant preferential issue of equity shares and warrants to Rasmalai Limited, a Cyprus-based entity, for an aggregate consideration of up to ₹3,150.00 crore (₹31,50,00,02,910.60).
The Board of Directors, in its meeting held on September 17, 2026, approved the issuance of up to 1,30,26,516 equity shares at an issue price of ₹985.17 per share, totaling ₹1,283.33 crore, and up to 1,89,47,664 warrants at the same price, with 25% payable upfront. This transaction will result in Rasmalai Limited holding approximately 24.87% of the company's post-issue share capital on a fully diluted basis.
The company also approved an increase in its authorized share capital from ₹115 crore to ₹150 crore, subject to shareholder approval. The Board has approved the adoption of amended and restated articles of association, incorporating special rights for the investor and rights for the promoters. An Extra-Ordinary General Meeting (EGM) is scheduled for October 15, 2026, at 11 AM to seek shareholder approval for these proposals.
The Investment Agreement, executed on September 17, 2026, outlines terms including the appointment of investor nominee directors and customary reserved matters rights. A promoter incentive structure, the 'Upside Share Arrangement', was also approved, where a promoter may receive a portion of the investor's profits upon divestment.
What to do with a filing like this
Yatharth Hospital & Trauma Care Services Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Yatharth Hospital & Trauma Care Services Limited. Read the original for the full detail.